Stocks Health care COCP
NASDAQ · Health careCocrystal Pharma, Inc. (COCP)
It posted a net loss of $9.9M. In fiscal 2025 capital spending exceeded operating cash flow by $8.2M. At June 30, 2026 it held $2.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Cocrystal Pharma, Inc. does
Cocrystal Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker COCP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$8.8M | -$0.78 | -$8.2M |
| 2024 | n/a | -$17.5M | -$1.72 | -$16.5M |
| 2023 | n/a | -$18M | -$1.87 | -$14.8M |
| 2022 | n/a | -$38.8M | -$4.77 | -$21.5M |
| 2021 | n/a | -$14.2M | -$0.16 | -$12.8M |
| 2020 | $2M | -$9.6M | -$0.17 | -$10.1M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Cocrystal Pharma, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 9, 2026
- August 18, 2026
- August 17, 2026
- August 13, 2026
- August 7, 2026Activist stake changed SCHEDULE 13D/A
- August 3, 2026
- July 17, 2026
- June 9, 2026
- June 3, 2026
- May 27, 2026Additional proxy material DEFA14A
Insider trades
What the people running Cocrystal Pharma, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $80.4K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 5, 2026 | Frost Phillip Md Et AlDirector, 10% owner | Boughtindirect | 10,000 | $9.8K |
| August 3, 2026 | Frost Phillip Md Et AlDirector, 10% owner | Boughtindirect | 75,000 | $70.6K |
Who owns COCP
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Phillip Frost, M.D.13D, may seek influence with 1 related filers | 13.9% | August 7, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 1,993,551 shares in total, about $2.3M at the last price.
| Holder | Shares |
|---|---|
| Frost Phillip Md Et AlDirector, 10% owner | 1,993,5511,993,551 held indirectly |
Questions about COCP
What does Cocrystal Pharma, Inc. do?
Cocrystal Pharma, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker COCP.
Is Cocrystal Pharma, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $9.9M.
When did Cocrystal Pharma, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 9, 2026.
Similar companies
Compare COCP with
Follow COCP
Get an email when Cocrystal Pharma, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow COCP: get an email when it filesWhere the numbers come from
Financial figures are the values Cocrystal Pharma, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.